The CD3G gene encodes the CD3 gamma (CD3γ) subunit, a critical component of the T-cell receptor (TCR) complex. The TCR-CD3 complex is essential for T-cell development, activation, and function. CD3G is expressed primarily in T lymphocytes, where it plays a fundamental role in translating antigen recognition into intracellular signaling events that drive T-cell responses.
Beyond its well-established role in adaptive immunity, emerging research suggests that CD3G and the T-cell compartment contribute to neuroinflammatory processes in neurodegenerative diseases. This page provides comprehensive information about the CD3G gene structure, protein function, and its implications in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions[1].
| CD3G (CD3 Gamma Subunit) | |
|---|---|
| Official Symbol | CD3G |
| Full Name | CD3 Gamma Subunit |
| Chromosomal Location | 11q23.3 |
| NCBI Gene ID | 915 |
| OMIM | 186740 |
| Ensembl ID | ENSG00000160654 |
| UniProt ID | P09693 |
The CD3G gene is located on chromosome 11q23.3 and consists of multiple exons that encode the CD3γ protein. The gene structure includes:
The CD3γ protein is a type I transmembrane glycoprotein consisting of:
The CD3γ chain pairs with CD3ε, CD3ζ, and CD3δ to form the complete TCR-CD3 complex. Each CD3 subunit contributes one or more ITAMs to the signaling apparatus of the TCR complex[2].
The TCR-CD3 complex is a multisubunit receptor essential for T-cell function:
CD3γ contributes to the proper assembly and surface expression of the TCR complex. Without CD3γ, TCR complexes fail to reach the cell surface, leading to severe T-cell immunodeficiency[3].
CD3γ contains an ITAM in its cytoplasmic tail. Upon TCR engagement:
This signaling cascade ultimately leads to T-cell proliferation, cytokine production, and effector functions[4].
CD3G is essential for T-cell development in the thymus:
Mutations in CD3G can lead to severe combined immunodeficiency due to impaired T-cell development[5].
While T cells are not traditionally considered resident brain cells, they play important roles in neuroinflammation:
In neurodegenerative diseases, T cell infiltration is commonly observed, and the TCR repertoire is altered[6].
In Alzheimer's disease, T cells contribute to neuroinflammation through multiple mechanisms[7]:
CD3+ T cells are found in AD brain tissue:
The T cell infiltrate includes both CD4+ and CD8+ subsets, each contributing differently to disease pathology.
T cells in AD produce pro-inflammatory cytokines:
Regulatory T cells (Tregs), which normally suppress inflammation, are often dysfunctional in AD:
T cells are increasingly recognized as important contributors to PD pathogenesis[8]:
CD3+ T cells infiltrate the substantia nigra in PD:
T cells in PD may recognize:
This suggests that antigen-specific T cell responses may contribute to disease progression.
T cells can contribute to dopaminergic neuron death through:
T cells play complex roles in ALS[9]:
T cell abnormalities in Huntington's disease include[10]:
T cells can damage neurons through multiple pathways:
T cells amplify neuroinflammation through:
While T cells are not typically considered antigen-presenting cells in the CNS, they can:
Targeting T cell-mediated inflammation represents a therapeutic strategy[11]:
Tregs are protective in neurodegeneration:
Immune checkpoint molecules modulate T cell function:
T cell markers may serve as biomarkers:
Stadan R, et al. T cells in neurodegenerative diseases: friends or foes?. Trends in Immunology. 2019. ↩︎
Minami Y, et al. The T-cell receptor/CD3 complex: structure and function. Annual Review of Immunology. 1987. ↩︎
Clements JL, et al. The T-cell receptor/CD3 complex in T-cell development and activation. Seminars in Immunology. 1994. ↩︎
Ashwell JD, et al. Signal transduction through the CD3/TCR complex. Annual Review of Immunology. 1988. ↩︎
van Meerwijk JP, et al. T-cell development and function in immunodeficient mice. Immunology. 2015. ↩︎
Larbi A, et al. T-cell dysregulation in Alzheimer's disease. Journal of Alzheimer's Disease. 2020. ↩︎
Pan X, et al. CD3+ T cells in Alzheimer's disease: role in pathogenesis and therapeutic potential. Journal of Neuroimmunology. 2018. ↩︎
Sukhbaatar G, et al. T-cell receptor signaling in Parkinson's disease. Parkinsonism & Related Disorders. 2020. ↩︎
Appel SH, et al. T cells in amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences. 2009. ↩︎
Lin J, et al. T-cell mediated cytotoxicity in Huntington's disease. Brain. 2018. ↩︎
Gupta V, et al. Targeting T-cell checkpoints for neurodegenerative disease therapy. Trends in Pharmacological Sciences. 2023. ↩︎